|
DE10252667A1
(de)
*
|
2002-11-11 |
2004-05-27 |
Grünenthal GmbH |
Spirocyclische Cyclohexan-Derivate
|
|
US7767689B2
(en)
*
|
2004-03-15 |
2010-08-03 |
Ptc Therapeutics, Inc. |
Carboline derivatives useful in the treatment of cancer
|
|
US8076353B2
(en)
|
2004-03-15 |
2011-12-13 |
Ptc Therapeutics, Inc. |
Inhibition of VEGF translation
|
|
US8076352B2
(en)
|
2004-03-15 |
2011-12-13 |
Ptc Therapeutics, Inc. |
Administration of carboline derivatives useful in the treatment of cancer and other diseases
|
|
ZA200608176B
(en)
|
2004-03-15 |
2008-05-28 |
Ptc Therapeutics Inc |
Carboline derivatives useful in the inhibition of angiogenesis
|
|
US9512125B2
(en)
|
2004-11-19 |
2016-12-06 |
The Regents Of The University Of California |
Substituted pyrazolo[3.4-D] pyrimidines as anti-inflammatory agents
|
|
DE102005016460A1
(de)
*
|
2005-04-11 |
2006-10-19 |
Grünenthal GmbH |
Spriocyclische Cyclohexanderivate zur Behandlung von Substanzabhängigkeit
|
|
WO2007002181A2
(en)
|
2005-06-24 |
2007-01-04 |
Eli Lilly And Company |
Tetrahydrocarbazole derivatives useful as androgen receptor modulators (sarm)
|
|
WO2007062175A2
(en)
*
|
2005-11-21 |
2007-05-31 |
Amgen Inc. |
Spiro-substituted tricyclic heterocycles cxcr3 antagonists
|
|
LT1993360T
(lt)
|
2005-12-28 |
2017-06-12 |
Vertex Pharmaceuticals Incorporated |
N-[2,4-bis(1,1-dimetiletil)-5-hidroksifenil]-1,4-dihidro-4-oksochinolin-3-karboksamido kieta forma
|
|
KR101499783B1
(ko)
|
2006-04-04 |
2015-03-09 |
더 리젠트스 오브 더 유니이버시티 오브 캘리포니아 |
키나제 길항물질
|
|
ES2470566T3
(es)
|
2006-07-19 |
2014-06-24 |
E.I. Du Pont De Nemours And Company |
Procedimiento para preparar 2-amino-5-halobenzamidas sustituidas en 3
|
|
ITMI20061581A1
(it)
*
|
2006-08-04 |
2008-02-05 |
Univ Bari |
Ligandi del recettore beta-3 adrenergico e loro uso in terapia
|
|
UA98777C2
(en)
|
2006-11-20 |
2012-06-25 |
Эли Лилли Энд Компани |
Tetrahydrocyclopenta[b]indole compounds as androgen receptor modulators
|
|
DE102007009235A1
(de)
*
|
2007-02-22 |
2008-09-18 |
Grünenthal GmbH |
Spirocyclische Cyclohexan-Derivate
|
|
US20100267712A1
(en)
*
|
2007-09-27 |
2010-10-21 |
The United States of America, as represented by the Secretary, Department of Health and |
Isoindoline compounds for the treatment of spinal muscular atrophy and other uses
|
|
US20110160232A1
(en)
|
2007-10-04 |
2011-06-30 |
Pingda Ren |
Certain chemical entities and therapeutic uses thereof
|
|
WO2009078423A1
(ja)
*
|
2007-12-18 |
2009-06-25 |
National University Corporation University Of Toyama |
アルドース還元酵素阻害活性を有する縮合三環化合物
|
|
US8193182B2
(en)
|
2008-01-04 |
2012-06-05 |
Intellikine, Inc. |
Substituted isoquinolin-1(2H)-ones, and methods of use thereof
|
|
AU2009204483B2
(en)
|
2008-01-04 |
2014-03-13 |
Intellikine, Llc |
Certain chemical entities, compositions and methods
|
|
US8993580B2
(en)
|
2008-03-14 |
2015-03-31 |
Intellikine Llc |
Benzothiazole kinase inhibitors and methods of use
|
|
JP5547099B2
(ja)
|
2008-03-14 |
2014-07-09 |
インテリカイン， エルエルシー |
キナーゼ阻害剤および使用方法
|
|
RU2514192C2
(ru)
|
2008-03-27 |
2014-04-27 |
Грюненталь Гмбх |
Гидроксиметилциклогексиламины
|
|
PL2260042T3
(pl)
|
2008-03-27 |
2012-02-29 |
Gruenenthal Gmbh |
Podstawione spirocykliczne pochodne cykloheksanu
|
|
PE20091823A1
(es)
|
2008-03-27 |
2009-12-10 |
Gruenenthal Chemie |
Ciclohexildiaminas sustituidas
|
|
DK2257526T3
(da)
*
|
2008-03-27 |
2012-02-06 |
Gruenenthal Gmbh |
Spiro(5,5)undecan-derivater
|
|
MX2010010407A
(es)
|
2008-03-27 |
2010-10-25 |
Gruenenthal Gmbh |
Derivados de 4-aminociclohexanos sustituidos.
|
|
CN102026974B
(zh)
|
2008-05-16 |
2013-08-28 |
伊莱利利公司 |
四氢环戊二烯并[b]吲哚雄激素受体调节剂
|
|
US20110224223A1
(en)
|
2008-07-08 |
2011-09-15 |
The Regents Of The University Of California, A California Corporation |
MTOR Modulators and Uses Thereof
|
|
MX2011000216A
(es)
|
2008-07-08 |
2011-03-29 |
Intellikine Inc |
Inhibidores de cinasa y metodos para su uso.
|
|
WO2010036380A1
(en)
|
2008-09-26 |
2010-04-01 |
Intellikine, Inc. |
Heterocyclic kinase inhibitors
|
|
WO2010045542A2
(en)
|
2008-10-16 |
2010-04-22 |
The Regents Of The University Of California |
Fused ring heteroaryl kinase inhibitors
|
|
US8476431B2
(en)
|
2008-11-03 |
2013-07-02 |
Itellikine LLC |
Benzoxazole kinase inhibitors and methods of use
|
|
EP2373315A4
(en)
*
|
2008-11-14 |
2012-06-27 |
Scripps Research Inst |
METHOD AND COMPOSITIONS RELATED TO TARGETING OF MONOACYLGLYCEROLLIPASE
|
|
WO2010129816A2
(en)
|
2009-05-07 |
2010-11-11 |
Intellikine, Inc. |
Heterocyclic compounds and uses thereof
|
|
MX373926B
(es)
|
2009-05-27 |
2020-07-10 |
Ptc Therapeutics Inc |
Metodos para tratar cancer y estados no neoplasicos.
|
|
WO2010138652A1
(en)
|
2009-05-27 |
2010-12-02 |
Ptc Therapeutics, Inc. |
Methods for treating kaposi sarcoma
|
|
US8703726B2
(en)
|
2009-05-27 |
2014-04-22 |
Ptc Therapeutics, Inc. |
Methods for treating prostate conditions
|
|
TW201100419A
(en)
|
2009-05-27 |
2011-01-01 |
Ptc Therapeutics Inc |
Processes for the preparation of substituted tetrahydro beta-carbolines
|
|
IN2012DN00352A
(enExample)
|
2009-06-16 |
2015-08-21 |
Bikam Pharmaceuticals Inc |
|
|
US8742100B2
(en)
|
2009-07-30 |
2014-06-03 |
National University Of Singapore |
Small molecule inhibitors of isoprenylcysteine carboxyl methyltransferase with potential anticancer activity
|
|
WO2011047384A2
(en)
|
2009-10-16 |
2011-04-21 |
The Regents Of The University Of California |
Methods of inhibiting ire1
|
|
US9556201B2
(en)
*
|
2009-10-29 |
2017-01-31 |
Glaxosmithkline Llc |
Bicyclic pyridines and analogs as sirtuin modulators
|
|
CA2788907A1
(en)
|
2010-02-04 |
2011-08-11 |
Radius Health, Inc. |
Selective androgen receptor modulators
|
|
SI2568806T1
(sl)
|
2010-05-12 |
2016-09-30 |
Radius Health, Inc. |
Režimi zdravljenja
|
|
JP5951600B2
(ja)
|
2010-05-21 |
2016-07-13 |
インフィニティー ファーマシューティカルズ， インコーポレイテッド |
キナーゼ調節のための、化合物、組成物および方法
|
|
WO2011155983A1
(en)
*
|
2010-06-07 |
2011-12-15 |
Bikam Pharmaceuticals Inc. |
Opsin-binding ligands, compositions and methods of use
|
|
US8822663B2
(en)
|
2010-08-06 |
2014-09-02 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
|
US9133182B2
(en)
|
2010-09-28 |
2015-09-15 |
Radius Health, Inc. |
Selective androgen receptor modulators
|
|
DK4108671T3
(da)
|
2010-10-01 |
2025-01-06 |
Modernatx Inc |
Modificerede nukleosider, nukleotider og nukleinsyrer samt anvendelser deraf
|
|
US8901133B2
(en)
|
2010-11-10 |
2014-12-02 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
|
WO2012071369A2
(en)
|
2010-11-24 |
2012-05-31 |
The Trustees Of Columbia University In The City Of New York |
A non-retinoid rbp4 antagonist for treatment of age-related macular degeneration and stargardt disease
|
|
GB201021103D0
(en)
|
2010-12-13 |
2011-01-26 |
Univ Leuven Kath |
New compounds for the treatment of neurodegenerative diseases
|
|
KR20180080358A
(ko)
|
2011-01-10 |
2018-07-11 |
인피니티 파마슈티칼스, 인코포레이티드 |
이소퀴놀린온 및 이의 고체 형태의 제조 방법
|
|
EP2671589A4
(en)
*
|
2011-02-02 |
2014-11-19 |
Public Univ Corp Nagoya City Univ |
MEDICAMENT FOR PREVENTING OR TREATING DISEASES RELATED TO INTRAOCULAR NEOVASCULARIZATION AND / OR INTRAOCULAR VASCULAR HYPERPERMEABILITY
|
|
JP6130305B2
(ja)
|
2011-02-23 |
2017-05-17 |
インテリカイン， エルエルシー |
キナーゼ阻害剤の組み合わせおよびそれらの使用
|
|
TW201309698A
(zh)
|
2011-03-18 |
2013-03-01 |
Ono Pharmaceutical Co |
四氫咔啉衍生物
|
|
JP2014511687A
(ja)
|
2011-03-31 |
2014-05-19 |
モデルナ セラピューティクス インコーポレイテッド |
工学操作された核酸の送達および製剤
|
|
CN103930422A
(zh)
|
2011-07-19 |
2014-07-16 |
无限药品股份有限公司 |
杂环化合物及其用途
|
|
EP2734530A1
(en)
|
2011-07-19 |
2014-05-28 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
|
CN103998442B
(zh)
|
2011-08-29 |
2016-09-14 |
无限药品股份有限公司 |
杂环化合物及其用途
|
|
MX370814B
(es)
|
2011-09-02 |
2020-01-08 |
Univ California |
Pirazolo[3,4-d]pirimidinas sustituidas y usos de las mismas.
|
|
US9464124B2
(en)
|
2011-09-12 |
2016-10-11 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
|
CN103030643B
(zh)
*
|
2011-09-29 |
2015-04-29 |
中国科学院化学研究所 |
六环吲哚类生物碱及其制备方法
|
|
JP6113737B2
(ja)
|
2011-10-03 |
2017-04-12 |
モデルナティエックス インコーポレイテッドＭｏｄｅｒｎａＴＸ，Ｉｎｃ． |
修飾型のヌクレオシド、ヌクレオチドおよび核酸、ならびにそれらの使用方法
|
|
AR088377A1
(es)
*
|
2011-10-20 |
2014-05-28 |
Siena Biotech Spa |
Proceso para la preparacion de 6-cloro-2,3,4,9-tetrahidro-1h-carbazol-1-carboxamida y compuestos intermedios de esta
|
|
KR20140102759A
(ko)
|
2011-12-16 |
2014-08-22 |
모더나 세라퓨틱스, 인코포레이티드 |
변형된 뉴클레오사이드, 뉴클레오타이드 및 핵산 조성물
|
|
EP2606726A1
(de)
|
2011-12-21 |
2013-06-26 |
Bayer CropScience AG |
N-Arylamidine-substituierte trifluoroethylsulfid-Derivate als Akarizide und Insektizide
|
|
HK1206612A1
(en)
|
2012-04-02 |
2016-01-15 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of secreted proteins
|
|
US9572897B2
(en)
|
2012-04-02 |
2017-02-21 |
Modernatx, Inc. |
Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
|
|
US9254311B2
(en)
|
2012-04-02 |
2016-02-09 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of proteins
|
|
EP2834259A4
(en)
|
2012-04-02 |
2016-08-24 |
Moderna Therapeutics Inc |
MODIFIED POLYNUCLEOTIDES
|
|
US9283287B2
(en)
|
2012-04-02 |
2016-03-15 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of nuclear proteins
|
|
US8940742B2
(en)
|
2012-04-10 |
2015-01-27 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
|
WO2013166037A1
(en)
|
2012-05-01 |
2013-11-07 |
The Trustees Of Columbia University In The City Of New York |
Non-retinoid antagonists for treatment of eye disorders
|
|
US8828998B2
(en)
|
2012-06-25 |
2014-09-09 |
Infinity Pharmaceuticals, Inc. |
Treatment of lupus, fibrotic conditions, and inflammatory myopathies and other disorders using PI3 kinase inhibitors
|
|
EP2690091A1
(en)
|
2012-07-25 |
2014-01-29 |
Studiengesellschaft Kohle mbH |
Process for preparing substituted indole derivatives
|
|
US20150210717A1
(en)
*
|
2012-09-13 |
2015-07-30 |
Baden-Württemberg Stiftung Gmbh |
Specific inhibitors of protein p21 as therapeutic agents
|
|
WO2014052669A1
(en)
|
2012-09-26 |
2014-04-03 |
The Regents Of The University Of California |
Modulation of ire1
|
|
IL291945B2
(en)
|
2012-11-01 |
2025-11-01 |
Infinity Pharmaceuticals Inc |
Treatment of cancers using pi3 kinase isoform modulators
|
|
US9597380B2
(en)
|
2012-11-26 |
2017-03-21 |
Modernatx, Inc. |
Terminally modified RNA
|
|
EP3495357B1
(en)
|
2013-03-14 |
2021-05-05 |
The Trustees of Columbia University in the City of New York |
4-phenylpiperidines, their preparation and use
|
|
US9637450B2
(en)
|
2013-03-14 |
2017-05-02 |
The Trustees Of Columbia University In The City Of New York |
Octahydrocyclopentapyrroles, their preparation and use
|
|
US9944644B2
(en)
|
2013-03-14 |
2018-04-17 |
The Trustees Of Columbia University In The City Of New York |
Octahydropyrrolopyrroles their preparation and use
|
|
WO2014151959A1
(en)
|
2013-03-14 |
2014-09-25 |
The Trustees Of Columbia University In The City Of New York |
N-alkyl-2-phenoxyethanamines, their preparation and use
|
|
US8980864B2
(en)
|
2013-03-15 |
2015-03-17 |
Moderna Therapeutics, Inc. |
Compositions and methods of altering cholesterol levels
|
|
US9481667B2
(en)
|
2013-03-15 |
2016-11-01 |
Infinity Pharmaceuticals, Inc. |
Salts and solid forms of isoquinolinones and composition comprising and methods of using the same
|
|
BR112015026513A2
(pt)
|
2013-04-17 |
2017-07-25 |
Pfizer |
derivados de n-piperidin-3-ilbenzamida para tratar as doenças cardiovasculares
|
|
US10561707B2
(en)
*
|
2013-09-08 |
2020-02-18 |
Technion Research And Development Foundation Ltd. |
Semaphorin 3C variants, compositions comprising said variants and methods of use thereof in treating eye diseases
|
|
US10023626B2
(en)
|
2013-09-30 |
2018-07-17 |
Modernatx, Inc. |
Polynucleotides encoding immune modulating polypeptides
|
|
EP3052521A1
(en)
|
2013-10-03 |
2016-08-10 |
Moderna Therapeutics, Inc. |
Polynucleotides encoding low density lipoprotein receptor
|
|
WO2015051241A1
(en)
|
2013-10-04 |
2015-04-09 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
|
MX389256B
(es)
|
2013-10-04 |
2025-03-20 |
Infinity Pharmaceuticals Inc |
Compuestos heterociclicos y usos de los mismos.
|
|
EP4066834A1
(en)
|
2014-03-19 |
2022-10-05 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds for use in the treatment of pi3k-gamma mediated disorders
|
|
CA2946538A1
(en)
|
2014-04-04 |
2015-10-08 |
Del Mar Pharmaceuticals |
Use of dianhydrogalactitol and analogs or derivatives thereof to treat non-small-cell carcinoma of the lung and ovarian cancer
|
|
US20150320755A1
(en)
|
2014-04-16 |
2015-11-12 |
Infinity Pharmaceuticals, Inc. |
Combination therapies
|
|
BR112016025356B1
(pt)
|
2014-04-30 |
2023-04-18 |
The Trustees Of Columbia University In The City Of New York |
Compostos de 4-fenilpiperidinas substituídas, composições e seus usos
|
|
CN111978319B
(zh)
*
|
2014-06-27 |
2023-08-11 |
诺格拉制药有限公司 |
芳基受体调制剂及其制备和使用方法
|
|
EP3171895A1
(en)
|
2014-07-23 |
2017-05-31 |
Modernatx, Inc. |
Modified polynucleotides for the production of intrabodies
|
|
WO2016014975A2
(en)
*
|
2014-07-25 |
2016-01-28 |
Northeastern University |
Urea/carbamates faah magl or dual faah/magl inhibitors and uses thereof
|
|
MX2017002985A
(es)
*
|
2014-09-10 |
2017-11-17 |
Epizyme Inc |
Inhibidores de smyd.
|
|
WO2016054491A1
(en)
|
2014-10-03 |
2016-04-07 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
|
EP3204358B1
(en)
|
2014-10-07 |
2018-09-19 |
Vertex Pharmaceuticals Incorporated |
Co-crystals of modulators of cystic fibrosis transmembrane conductance regulator
|
|
WO2017007755A1
(en)
|
2015-07-06 |
2017-01-12 |
Rodin Therapeutics, Inc. |
Heterobicyclic n-aminophenyl-amides as inhibitors of histone deacetylase
|
|
LT3319959T
(lt)
|
2015-07-06 |
2021-12-27 |
Alkermes, Inc. |
Histono deacetilazės hetero-halogeno inhibitoriai
|
|
CN108349985A
(zh)
|
2015-09-14 |
2018-07-31 |
无限药品股份有限公司 |
异喹啉酮的固体形式、其制备方法、包含其的组合物及其使用方法
|
|
US10759806B2
(en)
|
2016-03-17 |
2020-09-01 |
Infinity Pharmaceuticals, Inc. |
Isotopologues of isoquinolinone and quinazolinone compounds and uses thereof as PI3K kinase inhibitors
|
|
WO2017214269A1
(en)
|
2016-06-08 |
2017-12-14 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
|
RU2769527C2
(ru)
|
2016-06-22 |
2022-04-01 |
Эллипсес Фарма Лтд |
Способы лечения ar+ рака молочной железы
|
|
CA3028718A1
(en)
|
2016-06-24 |
2017-12-28 |
Infinity Pharmaceuticals, Inc. |
Combination therapies
|
|
ES2846833T3
(es)
|
2016-07-18 |
2021-07-29 |
Janssen Pharmaceutica Nv |
Ligandos de obtención de imágenes de tau por PET
|
|
US10624343B2
(en)
|
2016-08-26 |
2020-04-21 |
Sumitomo Chemical Company, Limited |
Phenyl urea compound, and use thereof
|
|
MX2019002314A
(es)
|
2016-08-26 |
2019-06-06 |
Sumitomo Chemical Co |
Compuesto de 1-acetil-fenil urea, y uso del mismo.
|
|
KR20190093205A
(ko)
|
2016-12-21 |
2019-08-08 |
바이오테릭스, 인코포레이티드 |
단백질 표적화에 사용하기 위한 티에노피롤 유도체, 조성물, 방법 및 이의 용도
|
|
US10793567B2
(en)
|
2017-01-11 |
2020-10-06 |
Rodin Therapeutics, Inc. |
Bicyclic inhibitors of histone deacetylase
|
|
WO2018165612A1
(en)
|
2017-03-10 |
2018-09-13 |
Rutgers, The State University Of New Jersey |
Bacterial efflux pump inhibitors
|
|
BR112019018691A2
(pt)
|
2017-03-10 |
2020-04-07 |
Rutgers, The State University Of New Jersey |
derivados de indol como inibidores de bomba de efluxo
|
|
US11938114B2
(en)
|
2017-03-10 |
2024-03-26 |
Rutgers, The State University Of New Jersey |
Bacterial efflux pump inhibitors
|
|
WO2018218192A1
(en)
|
2017-05-26 |
2018-11-29 |
Rutgers, The State University Of New Jersey |
Bacterial efflux pump inhibitors
|
|
US11786607B2
(en)
|
2017-06-15 |
2023-10-17 |
Modernatx, Inc. |
RNA formulations
|
|
WO2019005841A1
(en)
*
|
2017-06-26 |
2019-01-03 |
Rutgers, The State University Of New Jersey |
THERAPEUTIC COMPOUNDS AND METHODS FOR TREATING INFECTION
|
|
EP3664803A4
(en)
|
2017-08-01 |
2021-05-05 |
PTC Therapeutics, Inc. |
DHODH INHIBITOR FOR USE IN THE TREATMENT OF HEMATOLOGICAL CANCERS
|
|
EA039417B1
(ru)
|
2017-08-07 |
2022-01-25 |
Родин Терапеутикс, Инк. |
Бициклические ингибиторы гистондеацетилазы
|
|
AU2018326799A1
(en)
|
2017-08-31 |
2020-02-27 |
Modernatx, Inc. |
Methods of making lipid nanoparticles
|
|
US10882821B1
(en)
|
2017-09-26 |
2021-01-05 |
The Board Of Trustees Of The Leland Stanford Junior University |
Enantiomeric compound for the reduction of the deleterious activity of extended nucleotide repeat containing genes
|
|
EP3737361A4
(en)
|
2018-01-11 |
2021-08-25 |
Centaurus Therapeutics |
INHIBITORS OF DIHYDROCERAMIDE DESATURASE FOR THE TREATMENT OF DISEASES
|
|
US12090235B2
(en)
|
2018-09-20 |
2024-09-17 |
Modernatx, Inc. |
Preparation of lipid nanoparticles and methods of administration thereof
|
|
JP2024502270A
(ja)
|
2020-12-23 |
2024-01-18 |
リキュリウム アイピー ホールディングス リミテッド ライアビリティー カンパニー |
エストロゲン受容体調節薬
|
|
US20250034089A1
(en)
*
|
2021-11-19 |
2025-01-30 |
Nain Biotech (Hangzhou) Co., Ltd. |
Tetrahydrocarbazole compound, and pharmaceutical composition and use thereof
|
|
CN121219265A
(zh)
|
2023-05-10 |
2025-12-26 |
杭州拿因生物科技有限责任公司 |
四氢咔唑衍生物、其药物组合物及用途
|